Hologic Inc. Files 10-Q for Q2 2025

Ticker: HOLX · Form: 10-Q · Filed: May 2, 2025 · CIK: 859737

Sentiment: neutral

Topics: 10-Q, financials, healthcare

TL;DR

Hologic's Q2 2025 10-Q is in. Check product/service revs & balance sheet details from Sept '23.

AI Summary

Hologic Inc. filed its 10-Q for the period ending March 29, 2025. The company's fiscal year ends on September 28. Key financial data for the quarter and year-to-date periods are presented, including details on product and service revenues, and balance sheet items like common stock and retained earnings as of September 30, 2023.

Why It Matters

This filing provides investors with a quarterly update on Hologic's financial performance and position, crucial for understanding the company's trajectory in the medical technology sector.

Risk Assessment

Risk Level: low — This is a standard quarterly financial filing with no immediate red flags.

Key Numbers

Key Players & Entities

FAQ

What were Hologic's total revenues for the quarter ending March 29, 2025?

The filing does not explicitly state total revenues for the quarter ending March 29, 2025, but provides breakdowns for product and service revenues across different periods.

What is Hologic's primary business as indicated by the SIC code?

Hologic Inc.'s Standard Industrial Classification (SIC) code is 3844, which corresponds to X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS.

When does Hologic's fiscal year typically end?

Hologic's fiscal year ends on September 28.

What are the key balance sheet components reported as of September 30, 2023?

As of September 30, 2023, key balance sheet components include Common Stock, Additional Paid-In Capital, Retained Earnings, and Accumulated Other Comprehensive Income.

What is the SEC file number for Hologic Inc.?

The SEC file number for Hologic Inc. is 001-36214.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 2, 2025 regarding HOLOGIC INC (HOLX).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing